nodes	percent_of_prediction	percent_of_DWPC	metapath
Imatinib—PIP4K2C—rheumatoid arthritis	0.422	0.945	CbGaD
Imatinib—ALB—rheumatoid arthritis	0.0247	0.0552	CbGaD
Imatinib—ALB—Auranofin—rheumatoid arthritis	0.0245	0.0844	CbGbCtD
Imatinib—ABCG2—Leflunomide—rheumatoid arthritis	0.0229	0.0789	CbGbCtD
Imatinib—ABCG2—Sulfasalazine—rheumatoid arthritis	0.0142	0.0487	CbGbCtD
Imatinib—PTGS1—Sulfasalazine—rheumatoid arthritis	0.0131	0.045	CbGbCtD
Imatinib—ABCG2—Hydrocortisone—rheumatoid arthritis	0.0114	0.0391	CbGbCtD
Imatinib—ABCG2—Cyclosporine—rheumatoid arthritis	0.0107	0.0369	CbGbCtD
Imatinib—CYP1A2—Leflunomide—rheumatoid arthritis	0.00945	0.0325	CbGbCtD
Imatinib—CYP2C9—Leflunomide—rheumatoid arthritis	0.00852	0.0293	CbGbCtD
Imatinib—CYP3A7—Hydrocortisone—rheumatoid arthritis	0.00839	0.0289	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Hydrocortisone—rheumatoid arthritis	0.00839	0.0289	CbGbCtD
Imatinib—CYP3A7—Cyclosporine—rheumatoid arthritis	0.00793	0.0273	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Cyclosporine—rheumatoid arthritis	0.00793	0.0273	CbGbCtD
Imatinib—CYP3A5—Sulfasalazine—rheumatoid arthritis	0.00785	0.027	CbGbCtD
Imatinib—ALB—Prednisone—rheumatoid arthritis	0.0078	0.0269	CbGbCtD
Imatinib—CA6—submandibular gland—rheumatoid arthritis	0.00746	0.18	CbGeAlD
Imatinib—ABCG2—Dexamethasone—rheumatoid arthritis	0.00707	0.0243	CbGbCtD
Imatinib—ABCB1—Methylprednisolone—rheumatoid arthritis	0.00674	0.0232	CbGbCtD
Imatinib—CYP3A5—Hydrocortisone—rheumatoid arthritis	0.0063	0.0217	CbGbCtD
Imatinib—CYP3A5—Cyclosporine—rheumatoid arthritis	0.00595	0.0205	CbGbCtD
Imatinib—ABCG2—Methotrexate—rheumatoid arthritis	0.00568	0.0195	CbGbCtD
Imatinib—CYP3A4—Ergocalciferol—rheumatoid arthritis	0.00548	0.0188	CbGbCtD
Imatinib—CYP3A7-CYP3A51P—Dexamethasone—rheumatoid arthritis	0.00522	0.018	CbGbCtD
Imatinib—CYP3A7—Dexamethasone—rheumatoid arthritis	0.00522	0.018	CbGbCtD
Imatinib—CYP2C19—Prednisone—rheumatoid arthritis	0.00506	0.0174	CbGbCtD
Imatinib—CYP2C19—Cyclosporine—rheumatoid arthritis	0.0048	0.0165	CbGbCtD
Imatinib—ABCB1—Betamethasone—rheumatoid arthritis	0.00438	0.0151	CbGbCtD
Imatinib—ABCB1—Prednisolone—rheumatoid arthritis	0.00432	0.0149	CbGbCtD
Imatinib—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0041	0.0141	CbGbCtD
Imatinib—ABCB1—Prednisone—rheumatoid arthritis	0.00408	0.014	CbGbCtD
Imatinib—CYP3A4—Methylprednisolone—rheumatoid arthritis	0.00404	0.0139	CbGbCtD
Imatinib—CYP2C9—Cyclosporine—rheumatoid arthritis	0.00399	0.0137	CbGbCtD
Imatinib—CYP3A5—Dexamethasone—rheumatoid arthritis	0.00392	0.0135	CbGbCtD
Imatinib—ALB—Methotrexate—rheumatoid arthritis	0.00392	0.0135	CbGbCtD
Imatinib—ABCB1—Cyclosporine—rheumatoid arthritis	0.00387	0.0133	CbGbCtD
Imatinib—CYP2D6—Cyclosporine—rheumatoid arthritis	0.00365	0.0125	CbGbCtD
Imatinib—CYP2C19—Dexamethasone—rheumatoid arthritis	0.00316	0.0109	CbGbCtD
Imatinib—CYP3A4—Triamcinolone—rheumatoid arthritis	0.00306	0.0105	CbGbCtD
Imatinib—CA6—saliva—rheumatoid arthritis	0.00268	0.0649	CbGeAlD
Imatinib—CYP2C9—Dexamethasone—rheumatoid arthritis	0.00263	0.00904	CbGbCtD
Imatinib—CYP3A4—Betamethasone—rheumatoid arthritis	0.00263	0.00903	CbGbCtD
Imatinib—CYP3A4—Prednisolone—rheumatoid arthritis	0.00259	0.00891	CbGbCtD
Imatinib—ABCB1—Dexamethasone—rheumatoid arthritis	0.00255	0.00877	CbGbCtD
Imatinib—CYP3A4—Hydrocortisone—rheumatoid arthritis	0.00246	0.00845	CbGbCtD
Imatinib—CYP3A4—Prednisone—rheumatoid arthritis	0.00245	0.00842	CbGbCtD
Imatinib—CYP2D6—Dexamethasone—rheumatoid arthritis	0.0024	0.00826	CbGbCtD
Imatinib—CYP3A4—Cyclosporine—rheumatoid arthritis	0.00232	0.00798	CbGbCtD
Imatinib—ABCB1—Methotrexate—rheumatoid arthritis	0.00205	0.00705	CbGbCtD
Imatinib—CYP3A4—Dexamethasone—rheumatoid arthritis	0.00153	0.00525	CbGbCtD
Imatinib—Nilotinib—MAPK8—rheumatoid arthritis	0.0015	0.592	CrCbGaD
Imatinib—ORM1—saliva—rheumatoid arthritis	0.00143	0.0346	CbGeAlD
Imatinib—CA6—exocrine gland—rheumatoid arthritis	0.00136	0.0328	CbGeAlD
Imatinib—ABCA3—parotid gland—rheumatoid arthritis	0.00123	0.0298	CbGeAlD
Imatinib—ABCA3—saliva-secreting gland—rheumatoid arthritis	0.00118	0.0285	CbGeAlD
Imatinib—DDR1—parotid gland—rheumatoid arthritis	0.00114	0.0275	CbGeAlD
Imatinib—DDR1—saliva-secreting gland—rheumatoid arthritis	0.00109	0.0263	CbGeAlD
Imatinib—Nilotinib—BLK—rheumatoid arthritis	0.00104	0.408	CrCbGaD
Imatinib—KIT—exocrine gland—rheumatoid arthritis	0.000788	0.0191	CbGeAlD
Imatinib—ABCA3—tendon—rheumatoid arthritis	0.000744	0.018	CbGeAlD
Imatinib—CA6—parotid gland—rheumatoid arthritis	0.000707	0.0171	CbGeAlD
Imatinib—PIP4K2C—parotid gland—rheumatoid arthritis	0.000701	0.017	CbGeAlD
Imatinib—DDR1—tendon—rheumatoid arthritis	0.000687	0.0166	CbGeAlD
Imatinib—CA6—saliva-secreting gland—rheumatoid arthritis	0.000677	0.0164	CbGeAlD
Imatinib—PIP4K2C—saliva-secreting gland—rheumatoid arthritis	0.000671	0.0162	CbGeAlD
Imatinib—CA3—parotid gland—rheumatoid arthritis	0.000669	0.0162	CbGeAlD
Imatinib—CA3—connective tissue—rheumatoid arthritis	0.000589	0.0142	CbGeAlD
Imatinib—NQO2—parotid gland—rheumatoid arthritis	0.000515	0.0125	CbGeAlD
Imatinib—NQO2—saliva-secreting gland—rheumatoid arthritis	0.000493	0.0119	CbGeAlD
Imatinib—CA2—exocrine gland—rheumatoid arthritis	0.000467	0.0113	CbGeAlD
Imatinib—CA7—digestive system—rheumatoid arthritis	0.000464	0.0112	CbGeAlD
Imatinib—PDGFRA—connective tissue—rheumatoid arthritis	0.000452	0.0109	CbGeAlD
Imatinib—ABL2—tendon—rheumatoid arthritis	0.000448	0.0108	CbGeAlD
Imatinib—PIP4K2C—tendon—rheumatoid arthritis	0.000424	0.0103	CbGeAlD
Imatinib—CA12—connective tissue—rheumatoid arthritis	0.000417	0.0101	CbGeAlD
Imatinib—KIT—parotid gland—rheumatoid arthritis	0.000411	0.00993	CbGeAlD
Imatinib—CA9—digestive system—rheumatoid arthritis	0.000407	0.00985	CbGeAlD
Imatinib—CA3—tendon—rheumatoid arthritis	0.000405	0.00979	CbGeAlD
Imatinib—PDGFRB—parotid gland—rheumatoid arthritis	0.000401	0.0097	CbGeAlD
Imatinib—CSF1R—connective tissue—rheumatoid arthritis	0.000398	0.00962	CbGeAlD
Imatinib—KIT—saliva-secreting gland—rheumatoid arthritis	0.000393	0.00951	CbGeAlD
Imatinib—CA9—tendon—rheumatoid arthritis	0.000388	0.00938	CbGeAlD
Imatinib—PDGFRB—saliva-secreting gland—rheumatoid arthritis	0.000384	0.00929	CbGeAlD
Imatinib—CA14—tendon—rheumatoid arthritis	0.000368	0.00889	CbGeAlD
Imatinib—KIT—connective tissue—rheumatoid arthritis	0.000361	0.00874	CbGeAlD
Imatinib—ABL1—parotid gland—rheumatoid arthritis	0.000357	0.00864	CbGeAlD
Imatinib—PDGFRB—connective tissue—rheumatoid arthritis	0.000353	0.00854	CbGeAlD
Imatinib—ABL1—saliva-secreting gland—rheumatoid arthritis	0.000342	0.00828	CbGeAlD
Imatinib—PDGFRA—lymphoid tissue—rheumatoid arthritis	0.00033	0.00799	CbGeAlD
Imatinib—PDGFRA—digestive system—rheumatoid arthritis	0.000326	0.0079	CbGeAlD
Imatinib—ABL1—connective tissue—rheumatoid arthritis	0.000315	0.00761	CbGeAlD
Imatinib—NQO2—tendon—rheumatoid arthritis	0.000311	0.00753	CbGeAlD
Imatinib—PDGFRA—tendon—rheumatoid arthritis	0.000311	0.00751	CbGeAlD
Imatinib—SLC22A2—digestive system—rheumatoid arthritis	0.00031	0.0075	CbGeAlD
Imatinib—CA12—digestive system—rheumatoid arthritis	0.000301	0.00729	CbGeAlD
Imatinib—CSF1R—lymphoid tissue—rheumatoid arthritis	0.000291	0.00704	CbGeAlD
Imatinib—CSF1R—digestive system—rheumatoid arthritis	0.000287	0.00695	CbGeAlD
Imatinib—CSF1R—tendon—rheumatoid arthritis	0.000273	0.00662	CbGeAlD
Imatinib—KIT—lymphoid tissue—rheumatoid arthritis	0.000264	0.00639	CbGeAlD
Imatinib—SLC47A1—digestive system—rheumatoid arthritis	0.000262	0.00635	CbGeAlD
Imatinib—KIT—digestive system—rheumatoid arthritis	0.000261	0.00631	CbGeAlD
Imatinib—PDGFRB—lymphoid tissue—rheumatoid arthritis	0.000258	0.00624	CbGeAlD
Imatinib—PDGFRB—digestive system—rheumatoid arthritis	0.000255	0.00616	CbGeAlD
Imatinib—SLC47A1—tendon—rheumatoid arthritis	0.00025	0.00604	CbGeAlD
Imatinib—CA2—parotid gland—rheumatoid arthritis	0.000243	0.00589	CbGeAlD
Imatinib—PDGFRB—tendon—rheumatoid arthritis	0.000243	0.00587	CbGeAlD
Imatinib—CA1—lymphoid tissue—rheumatoid arthritis	0.000242	0.00584	CbGeAlD
Imatinib—CA1—digestive system—rheumatoid arthritis	0.000239	0.00577	CbGeAlD
Imatinib—CA2—saliva-secreting gland—rheumatoid arthritis	0.000233	0.00564	CbGeAlD
Imatinib—ABL1—lymphoid tissue—rheumatoid arthritis	0.00023	0.00556	CbGeAlD
Imatinib—ABL1—digestive system—rheumatoid arthritis	0.000227	0.00549	CbGeAlD
Imatinib—ABCG2—parotid gland—rheumatoid arthritis	0.000225	0.00545	CbGeAlD
Imatinib—ABL1—tendon—rheumatoid arthritis	0.000216	0.00523	CbGeAlD
Imatinib—ABCG2—saliva-secreting gland—rheumatoid arthritis	0.000216	0.00522	CbGeAlD
Imatinib—CA2—connective tissue—rheumatoid arthritis	0.000214	0.00518	CbGeAlD
Imatinib—CYP2C19—digestive system—rheumatoid arthritis	0.000169	0.00408	CbGeAlD
Imatinib—PTGS1—connective tissue—rheumatoid arthritis	0.000165	0.004	CbGeAlD
Imatinib—CA2—lymphoid tissue—rheumatoid arthritis	0.000157	0.00379	CbGeAlD
Imatinib—CA2—digestive system—rheumatoid arthritis	0.000155	0.00374	CbGeAlD
Imatinib—CA2—tendon—rheumatoid arthritis	0.000147	0.00356	CbGeAlD
Imatinib—CYP1A2—digestive system—rheumatoid arthritis	0.000138	0.00333	CbGeAlD
Imatinib—CYP3A5—digestive system—rheumatoid arthritis	0.000133	0.00322	CbGeAlD
Imatinib—CYP2C9—digestive system—rheumatoid arthritis	0.000131	0.00317	CbGeAlD
Imatinib—PTGS1—digestive system—rheumatoid arthritis	0.000119	0.00289	CbGeAlD
Imatinib—PTGS1—tendon—rheumatoid arthritis	0.000114	0.00275	CbGeAlD
Imatinib—CYP3A4—digestive system—rheumatoid arthritis	9.98e-05	0.00241	CbGeAlD
Imatinib—CYP2D6—digestive system—rheumatoid arthritis	9.82e-05	0.00238	CbGeAlD
Imatinib—ABCB1—lymphoid tissue—rheumatoid arthritis	7.15e-05	0.00173	CbGeAlD
Imatinib—ABCB1—digestive system—rheumatoid arthritis	7.06e-05	0.00171	CbGeAlD
Imatinib—Decreased appetite—Hydrocortisone—rheumatoid arthritis	3.45e-05	0.000272	CcSEcCtD
Imatinib—Pharyngitis—Methotrexate—rheumatoid arthritis	3.44e-05	0.000271	CcSEcCtD
Imatinib—Nausea—Leflunomide—rheumatoid arthritis	3.43e-05	0.000271	CcSEcCtD
Imatinib—Urinary tract disorder—Methotrexate—rheumatoid arthritis	3.43e-05	0.00027	CcSEcCtD
Imatinib—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	3.42e-05	0.00027	CcSEcCtD
Imatinib—Fatigue—Hydrocortisone—rheumatoid arthritis	3.42e-05	0.000269	CcSEcCtD
Imatinib—Vision blurred—Prednisone—rheumatoid arthritis	3.41e-05	0.000268	CcSEcCtD
Imatinib—Urethral disorder—Methotrexate—rheumatoid arthritis	3.4e-05	0.000268	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	3.4e-05	0.000268	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	3.39e-05	0.000267	CcSEcCtD
Imatinib—Pain—Hydrocortisone—rheumatoid arthritis	3.39e-05	0.000267	CcSEcCtD
Imatinib—Anaphylactic shock—Betamethasone—rheumatoid arthritis	3.39e-05	0.000267	CcSEcCtD
Imatinib—Oedema—Dexamethasone—rheumatoid arthritis	3.39e-05	0.000267	CcSEcCtD
Imatinib—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	3.39e-05	0.000267	CcSEcCtD
Imatinib—Oedema—Betamethasone—rheumatoid arthritis	3.39e-05	0.000267	CcSEcCtD
Imatinib—Insomnia—Triamcinolone—rheumatoid arthritis	3.38e-05	0.000266	CcSEcCtD
Imatinib—Insomnia—Methylprednisolone—rheumatoid arthritis	3.37e-05	0.000265	CcSEcCtD
Imatinib—Infection—Dexamethasone—rheumatoid arthritis	3.37e-05	0.000265	CcSEcCtD
Imatinib—Infection—Betamethasone—rheumatoid arthritis	3.37e-05	0.000265	CcSEcCtD
Imatinib—Ill-defined disorder—Prednisone—rheumatoid arthritis	3.35e-05	0.000264	CcSEcCtD
Imatinib—Paraesthesia—Triamcinolone—rheumatoid arthritis	3.35e-05	0.000264	CcSEcCtD
Imatinib—Feeling abnormal—Prednisolone—rheumatoid arthritis	3.35e-05	0.000264	CcSEcCtD
Imatinib—Paraesthesia—Methylprednisolone—rheumatoid arthritis	3.34e-05	0.000264	CcSEcCtD
Imatinib—Anaemia—Prednisone—rheumatoid arthritis	3.34e-05	0.000263	CcSEcCtD
Imatinib—Shock—Dexamethasone—rheumatoid arthritis	3.33e-05	0.000263	CcSEcCtD
Imatinib—Shock—Betamethasone—rheumatoid arthritis	3.33e-05	0.000263	CcSEcCtD
Imatinib—Dyspnoea—Triamcinolone—rheumatoid arthritis	3.33e-05	0.000262	CcSEcCtD
Imatinib—Nervous system disorder—Dexamethasone—rheumatoid arthritis	3.32e-05	0.000262	CcSEcCtD
Imatinib—Nervous system disorder—Betamethasone—rheumatoid arthritis	3.32e-05	0.000262	CcSEcCtD
Imatinib—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	3.32e-05	0.000261	CcSEcCtD
Imatinib—Thrombocytopenia—Betamethasone—rheumatoid arthritis	3.32e-05	0.000261	CcSEcCtD
Imatinib—Tachycardia—Dexamethasone—rheumatoid arthritis	3.31e-05	0.00026	CcSEcCtD
Imatinib—Tachycardia—Betamethasone—rheumatoid arthritis	3.31e-05	0.00026	CcSEcCtD
Imatinib—Angioedema—Prednisone—rheumatoid arthritis	3.3e-05	0.00026	CcSEcCtD
Imatinib—Hypersensitivity—Cyclosporine—rheumatoid arthritis	3.29e-05	0.000259	CcSEcCtD
Imatinib—Dyspepsia—Triamcinolone—rheumatoid arthritis	3.29e-05	0.000259	CcSEcCtD
Imatinib—Erythema multiforme—Methotrexate—rheumatoid arthritis	3.28e-05	0.000258	CcSEcCtD
Imatinib—Dyspepsia—Methylprednisolone—rheumatoid arthritis	3.28e-05	0.000258	CcSEcCtD
Imatinib—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	3.27e-05	0.000258	CcSEcCtD
Imatinib—Hyperhidrosis—Betamethasone—rheumatoid arthritis	3.27e-05	0.000258	CcSEcCtD
Imatinib—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	3.27e-05	0.000257	CcSEcCtD
Imatinib—Malaise—Prednisone—rheumatoid arthritis	3.26e-05	0.000257	CcSEcCtD
Imatinib—Vertigo—Prednisone—rheumatoid arthritis	3.25e-05	0.000256	CcSEcCtD
Imatinib—Eye disorder—Methotrexate—rheumatoid arthritis	3.24e-05	0.000255	CcSEcCtD
Imatinib—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	3.24e-05	0.000255	CcSEcCtD
Imatinib—Syncope—Prednisone—rheumatoid arthritis	3.24e-05	0.000255	CcSEcCtD
Imatinib—Tinnitus—Methotrexate—rheumatoid arthritis	3.24e-05	0.000255	CcSEcCtD
Imatinib—Anorexia—Dexamethasone—rheumatoid arthritis	3.23e-05	0.000254	CcSEcCtD
Imatinib—Anorexia—Betamethasone—rheumatoid arthritis	3.23e-05	0.000254	CcSEcCtD
Imatinib—Urticaria—Prednisolone—rheumatoid arthritis	3.23e-05	0.000254	CcSEcCtD
Imatinib—Cardiac disorder—Methotrexate—rheumatoid arthritis	3.22e-05	0.000254	CcSEcCtD
Imatinib—Fatigue—Triamcinolone—rheumatoid arthritis	3.22e-05	0.000254	CcSEcCtD
Imatinib—Fatigue—Methylprednisolone—rheumatoid arthritis	3.21e-05	0.000253	CcSEcCtD
Imatinib—Asthenia—Cyclosporine—rheumatoid arthritis	3.2e-05	0.000252	CcSEcCtD
Imatinib—Pain—Triamcinolone—rheumatoid arthritis	3.19e-05	0.000252	CcSEcCtD
Imatinib—Loss of consciousness—Prednisone—rheumatoid arthritis	3.18e-05	0.00025	CcSEcCtD
Imatinib—Hypotension—Betamethasone—rheumatoid arthritis	3.17e-05	0.000249	CcSEcCtD
Imatinib—Hypotension—Dexamethasone—rheumatoid arthritis	3.17e-05	0.000249	CcSEcCtD
Imatinib—Pruritus—Cyclosporine—rheumatoid arthritis	3.16e-05	0.000249	CcSEcCtD
Imatinib—Urticaria—Hydrocortisone—rheumatoid arthritis	3.15e-05	0.000248	CcSEcCtD
Imatinib—Angiopathy—Methotrexate—rheumatoid arthritis	3.15e-05	0.000248	CcSEcCtD
Imatinib—Immune system disorder—Methotrexate—rheumatoid arthritis	3.13e-05	0.000247	CcSEcCtD
Imatinib—Abdominal pain—Hydrocortisone—rheumatoid arthritis	3.13e-05	0.000247	CcSEcCtD
Imatinib—Body temperature increased—Hydrocortisone—rheumatoid arthritis	3.13e-05	0.000247	CcSEcCtD
Imatinib—Convulsion—Prednisone—rheumatoid arthritis	3.13e-05	0.000247	CcSEcCtD
Imatinib—Mediastinal disorder—Methotrexate—rheumatoid arthritis	3.13e-05	0.000246	CcSEcCtD
Imatinib—Hypertension—Prednisone—rheumatoid arthritis	3.12e-05	0.000246	CcSEcCtD
Imatinib—Chills—Methotrexate—rheumatoid arthritis	3.11e-05	0.000245	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	3.09e-05	0.000243	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	3.09e-05	0.000243	CcSEcCtD
Imatinib—Arthralgia—Prednisone—rheumatoid arthritis	3.08e-05	0.000242	CcSEcCtD
Imatinib—Myalgia—Prednisone—rheumatoid arthritis	3.08e-05	0.000242	CcSEcCtD
Imatinib—Feeling abnormal—Triamcinolone—rheumatoid arthritis	3.08e-05	0.000242	CcSEcCtD
Imatinib—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	3.07e-05	0.000242	CcSEcCtD
Imatinib—Anxiety—Prednisone—rheumatoid arthritis	3.07e-05	0.000242	CcSEcCtD
Imatinib—Alopecia—Methotrexate—rheumatoid arthritis	3.07e-05	0.000242	CcSEcCtD
Imatinib—Insomnia—Dexamethasone—rheumatoid arthritis	3.06e-05	0.000241	CcSEcCtD
Imatinib—Insomnia—Betamethasone—rheumatoid arthritis	3.06e-05	0.000241	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	3.06e-05	0.000241	CcSEcCtD
Imatinib—Diarrhoea—Cyclosporine—rheumatoid arthritis	3.05e-05	0.00024	CcSEcCtD
Imatinib—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	3.05e-05	0.00024	CcSEcCtD
Imatinib—Paraesthesia—Betamethasone—rheumatoid arthritis	3.04e-05	0.00024	CcSEcCtD
Imatinib—Paraesthesia—Dexamethasone—rheumatoid arthritis	3.04e-05	0.00024	CcSEcCtD
Imatinib—Discomfort—Prednisone—rheumatoid arthritis	3.04e-05	0.00024	CcSEcCtD
Imatinib—Mental disorder—Methotrexate—rheumatoid arthritis	3.04e-05	0.00024	CcSEcCtD
Imatinib—Erythema—Methotrexate—rheumatoid arthritis	3.02e-05	0.000238	CcSEcCtD
Imatinib—Malnutrition—Methotrexate—rheumatoid arthritis	3.02e-05	0.000238	CcSEcCtD
Imatinib—Hypersensitivity—Prednisolone—rheumatoid arthritis	2.99e-05	0.000236	CcSEcCtD
Imatinib—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.98e-05	0.000235	CcSEcCtD
Imatinib—Dyspepsia—Betamethasone—rheumatoid arthritis	2.98e-05	0.000235	CcSEcCtD
Imatinib—Urticaria—Triamcinolone—rheumatoid arthritis	2.97e-05	0.000234	CcSEcCtD
Imatinib—Urticaria—Methylprednisolone—rheumatoid arthritis	2.96e-05	0.000233	CcSEcCtD
Imatinib—Dysgeusia—Methotrexate—rheumatoid arthritis	2.96e-05	0.000233	CcSEcCtD
Imatinib—Body temperature increased—Triamcinolone—rheumatoid arthritis	2.95e-05	0.000233	CcSEcCtD
Imatinib—Dizziness—Cyclosporine—rheumatoid arthritis	2.95e-05	0.000232	CcSEcCtD
Imatinib—Anaphylactic shock—Prednisone—rheumatoid arthritis	2.95e-05	0.000232	CcSEcCtD
Imatinib—Oedema—Prednisone—rheumatoid arthritis	2.95e-05	0.000232	CcSEcCtD
Imatinib—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.94e-05	0.000232	CcSEcCtD
Imatinib—Decreased appetite—Betamethasone—rheumatoid arthritis	2.94e-05	0.000232	CcSEcCtD
Imatinib—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.94e-05	0.000232	CcSEcCtD
Imatinib—Infection—Prednisone—rheumatoid arthritis	2.93e-05	0.000231	CcSEcCtD
Imatinib—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.92e-05	0.00023	CcSEcCtD
Imatinib—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.92e-05	0.00023	CcSEcCtD
Imatinib—Back pain—Methotrexate—rheumatoid arthritis	2.92e-05	0.00023	CcSEcCtD
Imatinib—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	2.92e-05	0.00023	CcSEcCtD
Imatinib—Fatigue—Dexamethasone—rheumatoid arthritis	2.92e-05	0.00023	CcSEcCtD
Imatinib—Fatigue—Betamethasone—rheumatoid arthritis	2.92e-05	0.00023	CcSEcCtD
Imatinib—Shock—Prednisone—rheumatoid arthritis	2.9e-05	0.000229	CcSEcCtD
Imatinib—Pain—Dexamethasone—rheumatoid arthritis	2.9e-05	0.000228	CcSEcCtD
Imatinib—Pain—Betamethasone—rheumatoid arthritis	2.9e-05	0.000228	CcSEcCtD
Imatinib—Nervous system disorder—Prednisone—rheumatoid arthritis	2.89e-05	0.000228	CcSEcCtD
Imatinib—Tachycardia—Prednisone—rheumatoid arthritis	2.88e-05	0.000227	CcSEcCtD
Imatinib—Skin disorder—Prednisone—rheumatoid arthritis	2.87e-05	0.000226	CcSEcCtD
Imatinib—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.85e-05	0.000225	CcSEcCtD
Imatinib—Vision blurred—Methotrexate—rheumatoid arthritis	2.85e-05	0.000224	CcSEcCtD
Imatinib—Asthenia—Hydrocortisone—rheumatoid arthritis	2.84e-05	0.000224	CcSEcCtD
Imatinib—Vomiting—Cyclosporine—rheumatoid arthritis	2.84e-05	0.000223	CcSEcCtD
Imatinib—Rash—Cyclosporine—rheumatoid arthritis	2.81e-05	0.000222	CcSEcCtD
Imatinib—Anorexia—Prednisone—rheumatoid arthritis	2.81e-05	0.000222	CcSEcCtD
Imatinib—Dermatitis—Cyclosporine—rheumatoid arthritis	2.81e-05	0.000221	CcSEcCtD
Imatinib—Pruritus—Hydrocortisone—rheumatoid arthritis	2.81e-05	0.000221	CcSEcCtD
Imatinib—Ill-defined disorder—Methotrexate—rheumatoid arthritis	2.8e-05	0.000221	CcSEcCtD
Imatinib—Headache—Cyclosporine—rheumatoid arthritis	2.79e-05	0.00022	CcSEcCtD
Imatinib—Anaemia—Methotrexate—rheumatoid arthritis	2.79e-05	0.00022	CcSEcCtD
Imatinib—Feeling abnormal—Betamethasone—rheumatoid arthritis	2.79e-05	0.00022	CcSEcCtD
Imatinib—Feeling abnormal—Dexamethasone—rheumatoid arthritis	2.79e-05	0.00022	CcSEcCtD
Imatinib—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2.77e-05	0.000218	CcSEcCtD
Imatinib—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2.77e-05	0.000218	CcSEcCtD
Imatinib—Hypersensitivity—Triamcinolone—rheumatoid arthritis	2.75e-05	0.000217	CcSEcCtD
Imatinib—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	2.74e-05	0.000216	CcSEcCtD
Imatinib—Malaise—Methotrexate—rheumatoid arthritis	2.72e-05	0.000215	CcSEcCtD
Imatinib—Vertigo—Methotrexate—rheumatoid arthritis	2.71e-05	0.000214	CcSEcCtD
Imatinib—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.71e-05	0.000214	CcSEcCtD
Imatinib—Leukopenia—Methotrexate—rheumatoid arthritis	2.7e-05	0.000213	CcSEcCtD
Imatinib—Urticaria—Betamethasone—rheumatoid arthritis	2.69e-05	0.000212	CcSEcCtD
Imatinib—Urticaria—Dexamethasone—rheumatoid arthritis	2.69e-05	0.000212	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.69e-05	0.000212	CcSEcCtD
Imatinib—Dizziness—Prednisolone—rheumatoid arthritis	2.68e-05	0.000211	CcSEcCtD
Imatinib—Asthenia—Triamcinolone—rheumatoid arthritis	2.68e-05	0.000211	CcSEcCtD
Imatinib—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.68e-05	0.000211	CcSEcCtD
Imatinib—Abdominal pain—Betamethasone—rheumatoid arthritis	2.68e-05	0.000211	CcSEcCtD
Imatinib—Body temperature increased—Dexamethasone—rheumatoid arthritis	2.68e-05	0.000211	CcSEcCtD
Imatinib—Body temperature increased—Betamethasone—rheumatoid arthritis	2.68e-05	0.000211	CcSEcCtD
Imatinib—Asthenia—Methylprednisolone—rheumatoid arthritis	2.67e-05	0.000211	CcSEcCtD
Imatinib—Insomnia—Prednisone—rheumatoid arthritis	2.67e-05	0.00021	CcSEcCtD
Imatinib—Nausea—Cyclosporine—rheumatoid arthritis	2.65e-05	0.000209	CcSEcCtD
Imatinib—Paraesthesia—Prednisone—rheumatoid arthritis	2.65e-05	0.000209	CcSEcCtD
Imatinib—Pruritus—Triamcinolone—rheumatoid arthritis	2.64e-05	0.000208	CcSEcCtD
Imatinib—Cough—Methotrexate—rheumatoid arthritis	2.64e-05	0.000208	CcSEcCtD
Imatinib—Pruritus—Methylprednisolone—rheumatoid arthritis	2.64e-05	0.000208	CcSEcCtD
Imatinib—Dizziness—Hydrocortisone—rheumatoid arthritis	2.62e-05	0.000207	CcSEcCtD
Imatinib—Convulsion—Methotrexate—rheumatoid arthritis	2.62e-05	0.000206	CcSEcCtD
Imatinib—Dyspepsia—Prednisone—rheumatoid arthritis	2.6e-05	0.000205	CcSEcCtD
Imatinib—Arthralgia—Methotrexate—rheumatoid arthritis	2.57e-05	0.000203	CcSEcCtD
Imatinib—Myalgia—Methotrexate—rheumatoid arthritis	2.57e-05	0.000203	CcSEcCtD
Imatinib—Chest pain—Methotrexate—rheumatoid arthritis	2.57e-05	0.000203	CcSEcCtD
Imatinib—Decreased appetite—Prednisone—rheumatoid arthritis	2.56e-05	0.000202	CcSEcCtD
Imatinib—Rash—Prednisolone—rheumatoid arthritis	2.56e-05	0.000202	CcSEcCtD
Imatinib—Dermatitis—Prednisolone—rheumatoid arthritis	2.56e-05	0.000201	CcSEcCtD
Imatinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.55e-05	0.000201	CcSEcCtD
Imatinib—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.55e-05	0.000201	CcSEcCtD
Imatinib—Fatigue—Prednisone—rheumatoid arthritis	2.54e-05	0.0002	CcSEcCtD
Imatinib—Headache—Prednisolone—rheumatoid arthritis	2.54e-05	0.0002	CcSEcCtD
Imatinib—Discomfort—Methotrexate—rheumatoid arthritis	2.54e-05	0.0002	CcSEcCtD
Imatinib—Constipation—Prednisone—rheumatoid arthritis	2.52e-05	0.000199	CcSEcCtD
Imatinib—Vomiting—Hydrocortisone—rheumatoid arthritis	2.52e-05	0.000199	CcSEcCtD
Imatinib—Rash—Hydrocortisone—rheumatoid arthritis	2.5e-05	0.000197	CcSEcCtD
Imatinib—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.5e-05	0.000197	CcSEcCtD
Imatinib—Confusional state—Methotrexate—rheumatoid arthritis	2.49e-05	0.000196	CcSEcCtD
Imatinib—Headache—Hydrocortisone—rheumatoid arthritis	2.48e-05	0.000196	CcSEcCtD
Imatinib—Dizziness—Triamcinolone—rheumatoid arthritis	2.47e-05	0.000194	CcSEcCtD
Imatinib—Anaphylactic shock—Methotrexate—rheumatoid arthritis	2.47e-05	0.000194	CcSEcCtD
Imatinib—Dizziness—Methylprednisolone—rheumatoid arthritis	2.46e-05	0.000194	CcSEcCtD
Imatinib—Infection—Methotrexate—rheumatoid arthritis	2.45e-05	0.000193	CcSEcCtD
Imatinib—Feeling abnormal—Prednisone—rheumatoid arthritis	2.43e-05	0.000192	CcSEcCtD
Imatinib—Asthenia—Betamethasone—rheumatoid arthritis	2.43e-05	0.000191	CcSEcCtD
Imatinib—Asthenia—Dexamethasone—rheumatoid arthritis	2.43e-05	0.000191	CcSEcCtD
Imatinib—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.42e-05	0.00019	CcSEcCtD
Imatinib—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.41e-05	0.00019	CcSEcCtD
Imatinib—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.41e-05	0.00019	CcSEcCtD
Imatinib—Nausea—Prednisolone—rheumatoid arthritis	2.41e-05	0.00019	CcSEcCtD
Imatinib—Pruritus—Betamethasone—rheumatoid arthritis	2.4e-05	0.000189	CcSEcCtD
Imatinib—Pruritus—Dexamethasone—rheumatoid arthritis	2.4e-05	0.000189	CcSEcCtD
Imatinib—Skin disorder—Methotrexate—rheumatoid arthritis	2.39e-05	0.000189	CcSEcCtD
Imatinib—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.38e-05	0.000188	CcSEcCtD
Imatinib—Vomiting—Triamcinolone—rheumatoid arthritis	2.37e-05	0.000187	CcSEcCtD
Imatinib—Vomiting—Methylprednisolone—rheumatoid arthritis	2.37e-05	0.000187	CcSEcCtD
Imatinib—Nausea—Hydrocortisone—rheumatoid arthritis	2.36e-05	0.000186	CcSEcCtD
Imatinib—Rash—Triamcinolone—rheumatoid arthritis	2.35e-05	0.000185	CcSEcCtD
Imatinib—Dermatitis—Triamcinolone—rheumatoid arthritis	2.35e-05	0.000185	CcSEcCtD
Imatinib—Anorexia—Methotrexate—rheumatoid arthritis	2.35e-05	0.000185	CcSEcCtD
Imatinib—Rash—Methylprednisolone—rheumatoid arthritis	2.35e-05	0.000185	CcSEcCtD
Imatinib—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.35e-05	0.000185	CcSEcCtD
Imatinib—Urticaria—Prednisone—rheumatoid arthritis	2.34e-05	0.000185	CcSEcCtD
Imatinib—Headache—Triamcinolone—rheumatoid arthritis	2.34e-05	0.000184	CcSEcCtD
Imatinib—Headache—Methylprednisolone—rheumatoid arthritis	2.33e-05	0.000184	CcSEcCtD
Imatinib—Body temperature increased—Prednisone—rheumatoid arthritis	2.33e-05	0.000184	CcSEcCtD
Imatinib—Abdominal pain—Prednisone—rheumatoid arthritis	2.33e-05	0.000184	CcSEcCtD
Imatinib—Diarrhoea—Betamethasone—rheumatoid arthritis	2.32e-05	0.000183	CcSEcCtD
Imatinib—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.32e-05	0.000183	CcSEcCtD
Imatinib—Hypotension—Methotrexate—rheumatoid arthritis	2.3e-05	0.000181	CcSEcCtD
Imatinib—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	2.25e-05	0.000177	CcSEcCtD
Imatinib—Dizziness—Dexamethasone—rheumatoid arthritis	2.24e-05	0.000176	CcSEcCtD
Imatinib—Dizziness—Betamethasone—rheumatoid arthritis	2.24e-05	0.000176	CcSEcCtD
Imatinib—Insomnia—Methotrexate—rheumatoid arthritis	2.23e-05	0.000176	CcSEcCtD
Imatinib—Nausea—Triamcinolone—rheumatoid arthritis	2.22e-05	0.000175	CcSEcCtD
Imatinib—Paraesthesia—Methotrexate—rheumatoid arthritis	2.21e-05	0.000174	CcSEcCtD
Imatinib—Nausea—Methylprednisolone—rheumatoid arthritis	2.21e-05	0.000174	CcSEcCtD
Imatinib—Dyspnoea—Methotrexate—rheumatoid arthritis	2.2e-05	0.000173	CcSEcCtD
Imatinib—Somnolence—Methotrexate—rheumatoid arthritis	2.19e-05	0.000173	CcSEcCtD
Imatinib—Hypersensitivity—Prednisone—rheumatoid arthritis	2.17e-05	0.000171	CcSEcCtD
Imatinib—Dyspepsia—Methotrexate—rheumatoid arthritis	2.17e-05	0.000171	CcSEcCtD
Imatinib—Vomiting—Dexamethasone—rheumatoid arthritis	2.15e-05	0.00017	CcSEcCtD
Imatinib—Vomiting—Betamethasone—rheumatoid arthritis	2.15e-05	0.00017	CcSEcCtD
Imatinib—Decreased appetite—Methotrexate—rheumatoid arthritis	2.14e-05	0.000169	CcSEcCtD
Imatinib—Rash—Dexamethasone—rheumatoid arthritis	2.14e-05	0.000168	CcSEcCtD
Imatinib—Rash—Betamethasone—rheumatoid arthritis	2.14e-05	0.000168	CcSEcCtD
Imatinib—Dermatitis—Dexamethasone—rheumatoid arthritis	2.13e-05	0.000168	CcSEcCtD
Imatinib—Dermatitis—Betamethasone—rheumatoid arthritis	2.13e-05	0.000168	CcSEcCtD
Imatinib—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	2.13e-05	0.000168	CcSEcCtD
Imatinib—Fatigue—Methotrexate—rheumatoid arthritis	2.13e-05	0.000167	CcSEcCtD
Imatinib—Headache—Betamethasone—rheumatoid arthritis	2.12e-05	0.000167	CcSEcCtD
Imatinib—Headache—Dexamethasone—rheumatoid arthritis	2.12e-05	0.000167	CcSEcCtD
Imatinib—Asthenia—Prednisone—rheumatoid arthritis	2.12e-05	0.000167	CcSEcCtD
Imatinib—Pain—Methotrexate—rheumatoid arthritis	2.11e-05	0.000166	CcSEcCtD
Imatinib—Pruritus—Prednisone—rheumatoid arthritis	2.09e-05	0.000164	CcSEcCtD
Imatinib—Feeling abnormal—Methotrexate—rheumatoid arthritis	2.03e-05	0.00016	CcSEcCtD
Imatinib—Diarrhoea—Prednisone—rheumatoid arthritis	2.02e-05	0.000159	CcSEcCtD
Imatinib—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	2.02e-05	0.000159	CcSEcCtD
Imatinib—Nausea—Betamethasone—rheumatoid arthritis	2.01e-05	0.000159	CcSEcCtD
Imatinib—Nausea—Dexamethasone—rheumatoid arthritis	2.01e-05	0.000159	CcSEcCtD
Imatinib—Urticaria—Methotrexate—rheumatoid arthritis	1.96e-05	0.000154	CcSEcCtD
Imatinib—Dizziness—Prednisone—rheumatoid arthritis	1.95e-05	0.000154	CcSEcCtD
Imatinib—Body temperature increased—Methotrexate—rheumatoid arthritis	1.95e-05	0.000154	CcSEcCtD
Imatinib—Abdominal pain—Methotrexate—rheumatoid arthritis	1.95e-05	0.000154	CcSEcCtD
Imatinib—Vomiting—Prednisone—rheumatoid arthritis	1.88e-05	0.000148	CcSEcCtD
Imatinib—Rash—Prednisone—rheumatoid arthritis	1.86e-05	0.000147	CcSEcCtD
Imatinib—Dermatitis—Prednisone—rheumatoid arthritis	1.86e-05	0.000146	CcSEcCtD
Imatinib—Headache—Prednisone—rheumatoid arthritis	1.85e-05	0.000146	CcSEcCtD
Imatinib—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.82e-05	0.000143	CcSEcCtD
Imatinib—Asthenia—Methotrexate—rheumatoid arthritis	1.77e-05	0.000139	CcSEcCtD
Imatinib—Nausea—Prednisone—rheumatoid arthritis	1.75e-05	0.000138	CcSEcCtD
Imatinib—Pruritus—Methotrexate—rheumatoid arthritis	1.74e-05	0.000137	CcSEcCtD
Imatinib—Diarrhoea—Methotrexate—rheumatoid arthritis	1.69e-05	0.000133	CcSEcCtD
Imatinib—Dizziness—Methotrexate—rheumatoid arthritis	1.63e-05	0.000128	CcSEcCtD
Imatinib—Vomiting—Methotrexate—rheumatoid arthritis	1.57e-05	0.000123	CcSEcCtD
Imatinib—Rash—Methotrexate—rheumatoid arthritis	1.55e-05	0.000122	CcSEcCtD
Imatinib—Dermatitis—Methotrexate—rheumatoid arthritis	1.55e-05	0.000122	CcSEcCtD
Imatinib—Headache—Methotrexate—rheumatoid arthritis	1.54e-05	0.000122	CcSEcCtD
Imatinib—Nausea—Methotrexate—rheumatoid arthritis	1.46e-05	0.000115	CcSEcCtD
Imatinib—PDGFRA—Immune System—IL2—rheumatoid arthritis	2.61e-06	2.84e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TYK2—rheumatoid arthritis	2.61e-06	2.84e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—PTGS2—rheumatoid arthritis	2.6e-06	2.83e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2RA—rheumatoid arthritis	2.59e-06	2.82e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—GC—rheumatoid arthritis	2.59e-06	2.82e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGES—rheumatoid arthritis	2.59e-06	2.82e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—NFKB1—rheumatoid arthritis	2.58e-06	2.81e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IFNG—rheumatoid arthritis	2.58e-06	2.81e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6ST—rheumatoid arthritis	2.58e-06	2.8e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—C3—rheumatoid arthritis	2.57e-06	2.8e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—NOS3—rheumatoid arthritis	2.56e-06	2.79e-05	CbGpPWpGaD
Imatinib—LCK—Disease—NOS2—rheumatoid arthritis	2.56e-06	2.78e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—CD4—rheumatoid arthritis	2.56e-06	2.78e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.55e-06	2.77e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ACP5—rheumatoid arthritis	2.54e-06	2.77e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—B3GNT2—rheumatoid arthritis	2.54e-06	2.77e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—MAPK8—rheumatoid arthritis	2.54e-06	2.76e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CD80—rheumatoid arthritis	2.54e-06	2.76e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—NOS3—rheumatoid arthritis	2.54e-06	2.76e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—FN1—rheumatoid arthritis	2.51e-06	2.73e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6ST—rheumatoid arthritis	2.5e-06	2.72e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—CD4—rheumatoid arthritis	2.49e-06	2.71e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6R—rheumatoid arthritis	2.49e-06	2.71e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALOX5—rheumatoid arthritis	2.49e-06	2.71e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP3—rheumatoid arthritis	2.48e-06	2.7e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CD80—rheumatoid arthritis	2.48e-06	2.7e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALOX5—rheumatoid arthritis	2.47e-06	2.68e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—ENO1—rheumatoid arthritis	2.46e-06	2.67e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—NFKB1—rheumatoid arthritis	2.45e-06	2.66e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL2—rheumatoid arthritis	2.43e-06	2.65e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—POMC—rheumatoid arthritis	2.41e-06	2.62e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PLB1—rheumatoid arthritis	2.41e-06	2.62e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—MAPK8—rheumatoid arthritis	2.4e-06	2.61e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CD80—rheumatoid arthritis	2.4e-06	2.61e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—LEP—rheumatoid arthritis	2.4e-06	2.6e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—MTHFR—rheumatoid arthritis	2.39e-06	2.6e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—PTK2—rheumatoid arthritis	2.39e-06	2.6e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.38e-06	2.59e-05	CbGpPWpGaD
Imatinib—PDGFRB—Innate Immune System—IL6—rheumatoid arthritis	2.37e-06	2.58e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—MTHFR—rheumatoid arthritis	2.37e-06	2.58e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—MTHFR—rheumatoid arthritis	2.37e-06	2.57e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL1B—rheumatoid arthritis	2.36e-06	2.57e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—CD4—rheumatoid arthritis	2.36e-06	2.57e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CCL2—rheumatoid arthritis	2.36e-06	2.57e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6R—rheumatoid arthritis	2.35e-06	2.56e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL2—rheumatoid arthritis	2.35e-06	2.56e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL5—rheumatoid arthritis	2.35e-06	2.55e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—PTGS2—rheumatoid arthritis	2.34e-06	2.55e-05	CbGpPWpGaD
Imatinib—ABL1—Innate Immune System—IL6—rheumatoid arthritis	2.31e-06	2.52e-05	CbGpPWpGaD
Imatinib—LCK—Hemostasis—TP53—rheumatoid arthritis	2.31e-06	2.51e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CSF2—rheumatoid arthritis	2.31e-06	2.51e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MMP9—rheumatoid arthritis	2.3e-06	2.51e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL1B—rheumatoid arthritis	2.3e-06	2.5e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6R—rheumatoid arthritis	2.3e-06	2.5e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—MTHFR—rheumatoid arthritis	2.3e-06	2.5e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL2—rheumatoid arthritis	2.29e-06	2.49e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—BGN—rheumatoid arthritis	2.29e-06	2.49e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—POMC—rheumatoid arthritis	2.28e-06	2.48e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.28e-06	2.48e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—TYK2—rheumatoid arthritis	2.27e-06	2.47e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—FN1—rheumatoid arthritis	2.26e-06	2.46e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6ST—rheumatoid arthritis	2.25e-06	2.45e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.24e-06	2.44e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CCL2—rheumatoid arthritis	2.23e-06	2.43e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6R—rheumatoid arthritis	2.23e-06	2.42e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—MTHFR—rheumatoid arthritis	2.21e-06	2.4e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ENO1—rheumatoid arthritis	2.21e-06	2.4e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—NFKB1—rheumatoid arthritis	2.2e-06	2.4e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—SPP1—rheumatoid arthritis	2.17e-06	2.36e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	2.17e-06	2.36e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	2.17e-06	2.36e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—MAPK8—rheumatoid arthritis	2.17e-06	2.36e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CD80—rheumatoid arthritis	2.17e-06	2.36e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ENO1—rheumatoid arthritis	2.15e-06	2.34e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—IL2—rheumatoid arthritis	2.15e-06	2.34e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—NFKB1—rheumatoid arthritis	2.15e-06	2.33e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TYK2—rheumatoid arthritis	2.14e-06	2.33e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IFNG—rheumatoid arthritis	2.12e-06	2.31e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	2.11e-06	2.3e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCR5—rheumatoid arthritis	2.11e-06	2.3e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MED1—rheumatoid arthritis	2.11e-06	2.3e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—MAPK8—rheumatoid arthritis	2.11e-06	2.3e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALOX5—rheumatoid arthritis	2.11e-06	2.29e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NOS3—rheumatoid arthritis	2.1e-06	2.29e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TYK2—rheumatoid arthritis	2.1e-06	2.28e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2RA—rheumatoid arthritis	2.08e-06	2.26e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.07e-06	2.25e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—C3—rheumatoid arthritis	2.06e-06	2.25e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—POMC—rheumatoid arthritis	2.06e-06	2.24e-05	CbGpPWpGaD
Imatinib—LCK—Disease—NOS3—rheumatoid arthritis	2.06e-06	2.24e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—CAT—rheumatoid arthritis	2.05e-06	2.23e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—CD4—rheumatoid arthritis	2.05e-06	2.23e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TYK2—rheumatoid arthritis	2.03e-06	2.21e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	2.03e-06	2.21e-05	CbGpPWpGaD
Imatinib—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	2.01e-06	2.19e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CCL2—rheumatoid arthritis	2.01e-06	2.19e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ENO1—rheumatoid arthritis	2.01e-06	2.19e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6R—rheumatoid arthritis	2.01e-06	2.18e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NOS3—rheumatoid arthritis	1.99e-06	2.17e-05	CbGpPWpGaD
Imatinib—KIT—Disease—TGFB1—rheumatoid arthritis	1.99e-06	2.16e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.98e-06	2.15e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—B3GNT2—rheumatoid arthritis	1.96e-06	2.14e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ACP5—rheumatoid arthritis	1.96e-06	2.14e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—LEP—rheumatoid arthritis	1.92e-06	2.09e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—POMC—rheumatoid arthritis	1.91e-06	2.08e-05	CbGpPWpGaD
Imatinib—LCK—Innate Immune System—IL6—rheumatoid arthritis	1.91e-06	2.07e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.9e-06	2.07e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.9e-06	2.06e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—POMC—rheumatoid arthritis	1.9e-06	2.06e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL1B—rheumatoid arthritis	1.9e-06	2.06e-05	CbGpPWpGaD
Imatinib—LCK—Disease—CD4—rheumatoid arthritis	1.89e-06	2.06e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—POMC—rheumatoid arthritis	1.89e-06	2.06e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL2—rheumatoid arthritis	1.89e-06	2.05e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—TGFB1—rheumatoid arthritis	1.88e-06	2.05e-05	CbGpPWpGaD
Imatinib—LCK—Disease—PTGS2—rheumatoid arthritis	1.88e-06	2.05e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—CXCL8—rheumatoid arthritis	1.87e-06	2.03e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	1.85e-06	2.02e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—POMC—rheumatoid arthritis	1.84e-06	2e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—VEGFA—rheumatoid arthritis	1.83e-06	1.99e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TYK2—rheumatoid arthritis	1.83e-06	1.99e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—FN1—rheumatoid arthritis	1.81e-06	1.97e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6ST—rheumatoid arthritis	1.81e-06	1.96e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NOS3—rheumatoid arthritis	1.79e-06	1.95e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL2—rheumatoid arthritis	1.78e-06	1.94e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—CAT—rheumatoid arthritis	1.77e-06	1.92e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—NFKB1—rheumatoid arthritis	1.77e-06	1.92e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—BGN—rheumatoid arthritis	1.77e-06	1.92e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—CXCL8—rheumatoid arthritis	1.77e-06	1.92e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—POMC—rheumatoid arthritis	1.76e-06	1.92e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—ALB—rheumatoid arthritis	1.74e-06	1.9e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—MAPK8—rheumatoid arthritis	1.74e-06	1.89e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CD80—rheumatoid arthritis	1.74e-06	1.89e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.73e-06	1.88e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—ALB—rheumatoid arthritis	1.73e-06	1.88e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—ALB—rheumatoid arthritis	1.73e-06	1.88e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ENO1—rheumatoid arthritis	1.72e-06	1.87e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—MTHFR—rheumatoid arthritis	1.71e-06	1.86e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—TGFB1—rheumatoid arthritis	1.69e-06	1.84e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	1.69e-06	1.84e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL2—rheumatoid arthritis	1.69e-06	1.84e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MMP9—rheumatoid arthritis	1.69e-06	1.84e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TGFB1—rheumatoid arthritis	1.68e-06	1.83e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—ALB—rheumatoid arthritis	1.68e-06	1.82e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—NFKB1—rheumatoid arthritis	1.67e-06	1.82e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—NOS3—rheumatoid arthritis	1.67e-06	1.81e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—NOS3—rheumatoid arthritis	1.65e-06	1.8e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—POMC—rheumatoid arthritis	1.65e-06	1.8e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—NOS3—rheumatoid arthritis	1.65e-06	1.8e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—MAPK8—rheumatoid arthritis	1.64e-06	1.79e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALOX5—rheumatoid arthritis	1.63e-06	1.77e-05	CbGpPWpGaD
Imatinib—KIT—Immune System—IL6—rheumatoid arthritis	1.62e-06	1.76e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CCL2—rheumatoid arthritis	1.62e-06	1.76e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6R—rheumatoid arthritis	1.61e-06	1.75e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—ALB—rheumatoid arthritis	1.61e-06	1.75e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—NOS3—rheumatoid arthritis	1.6e-06	1.74e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MMP9—rheumatoid arthritis	1.6e-06	1.74e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—CXCL8—rheumatoid arthritis	1.59e-06	1.73e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—CAT—rheumatoid arthritis	1.59e-06	1.73e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—NFKB1—rheumatoid arthritis	1.58e-06	1.72e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—TP53—rheumatoid arthritis	1.56e-06	1.7e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—MAPK8—rheumatoid arthritis	1.55e-06	1.69e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—CAT—rheumatoid arthritis	1.55e-06	1.69e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—NOS3—rheumatoid arthritis	1.54e-06	1.67e-05	CbGpPWpGaD
Imatinib—PDGFRA—Immune System—IL6—rheumatoid arthritis	1.54e-06	1.67e-05	CbGpPWpGaD
Imatinib—ABCG2—Metabolism—PTGS2—rheumatoid arthritis	1.53e-06	1.66e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL2—rheumatoid arthritis	1.52e-06	1.65e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—VEGFA—rheumatoid arthritis	1.52e-06	1.65e-05	CbGpPWpGaD
Imatinib—CYP3A7—Metabolism—PTGS2—rheumatoid arthritis	1.51e-06	1.64e-05	CbGpPWpGaD
Imatinib—SLC22A2—Metabolism—PTGS2—rheumatoid arthritis	1.51e-06	1.64e-05	CbGpPWpGaD
Imatinib—KIT—Disease—IL6—rheumatoid arthritis	1.5e-06	1.63e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—rheumatoid arthritis	1.48e-06	1.61e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—MTHFR—rheumatoid arthritis	1.48e-06	1.61e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TYK2—rheumatoid arthritis	1.47e-06	1.6e-05	CbGpPWpGaD
Imatinib—PTGS1—Metabolism—PTGS2—rheumatoid arthritis	1.47e-06	1.59e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—CAT—rheumatoid arthritis	1.46e-06	1.59e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—CAT—rheumatoid arthritis	1.45e-06	1.57e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NOS3—rheumatoid arthritis	1.44e-06	1.57e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MMP9—rheumatoid arthritis	1.44e-06	1.57e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—VEGFA—rheumatoid arthritis	1.43e-06	1.56e-05	CbGpPWpGaD
Imatinib—NTRK1—Signaling Pathways—IL6—rheumatoid arthritis	1.43e-06	1.56e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—NFKB1—rheumatoid arthritis	1.42e-06	1.55e-05	CbGpPWpGaD
Imatinib—PDGFRA—Disease—IL6—rheumatoid arthritis	1.42e-06	1.54e-05	CbGpPWpGaD
Imatinib—SLC22A1—Metabolism—PTGS2—rheumatoid arthritis	1.41e-06	1.53e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—MAPK8—rheumatoid arthritis	1.4e-06	1.52e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TGFB1—rheumatoid arthritis	1.39e-06	1.51e-05	CbGpPWpGaD
Imatinib—PDGFRB—Immune System—IL6—rheumatoid arthritis	1.38e-06	1.5e-05	CbGpPWpGaD
Imatinib—ALB—Hemostasis—TP53—rheumatoid arthritis	1.38e-06	1.5e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—POMC—rheumatoid arthritis	1.37e-06	1.49e-05	CbGpPWpGaD
Imatinib—LCK—Disease—TGFB1—rheumatoid arthritis	1.36e-06	1.48e-05	CbGpPWpGaD
Imatinib—ABL1—Immune System—IL6—rheumatoid arthritis	1.35e-06	1.47e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ENO1—rheumatoid arthritis	1.33e-06	1.44e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—MTHFR—rheumatoid arthritis	1.33e-06	1.44e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TGFB1—rheumatoid arthritis	1.32e-06	1.43e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	1.29e-06	1.41e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—VEGFA—rheumatoid arthritis	1.29e-06	1.41e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—CXCL8—rheumatoid arthritis	1.28e-06	1.39e-05	CbGpPWpGaD
Imatinib—PDGFRB—Disease—IL6—rheumatoid arthritis	1.28e-06	1.39e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—ALB—rheumatoid arthritis	1.25e-06	1.36e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—CAT—rheumatoid arthritis	1.24e-06	1.35e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL2—rheumatoid arthritis	1.22e-06	1.33e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	1.22e-06	1.33e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—MTHFR—rheumatoid arthritis	1.21e-06	1.31e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—NOS3—rheumatoid arthritis	1.2e-06	1.3e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TGFB1—rheumatoid arthritis	1.19e-06	1.29e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—POMC—rheumatoid arthritis	1.18e-06	1.28e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MMP9—rheumatoid arthritis	1.16e-06	1.26e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—TP53—rheumatoid arthritis	1.15e-06	1.25e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—NFKB1—rheumatoid arthritis	1.14e-06	1.24e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—MAPK8—rheumatoid arthritis	1.12e-06	1.22e-05	CbGpPWpGaD
Imatinib—LCK—Immune System—IL6—rheumatoid arthritis	1.11e-06	1.21e-05	CbGpPWpGaD
Imatinib—CYP3A5—Metabolism—PTGS2—rheumatoid arthritis	1.09e-06	1.19e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—TP53—rheumatoid arthritis	1.08e-06	1.18e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—POMC—rheumatoid arthritis	1.06e-06	1.15e-05	CbGpPWpGaD
Imatinib—KIT—Signaling Pathways—IL6—rheumatoid arthritis	1.05e-06	1.14e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—VEGFA—rheumatoid arthritis	1.04e-06	1.13e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—POMC—rheumatoid arthritis	1.03e-06	1.12e-05	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—MTHFR—rheumatoid arthritis	1.03e-06	1.12e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—NOS3—rheumatoid arthritis	1.03e-06	1.12e-05	CbGpPWpGaD
Imatinib—LCK—Disease—IL6—rheumatoid arthritis	1.02e-06	1.11e-05	CbGpPWpGaD
Imatinib—PDGFRA—Signaling Pathways—IL6—rheumatoid arthritis	9.92e-07	1.08e-05	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—TP53—rheumatoid arthritis	9.77e-07	1.06e-05	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—POMC—rheumatoid arthritis	9.75e-07	1.06e-05	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—POMC—rheumatoid arthritis	9.66e-07	1.05e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—ALB—rheumatoid arthritis	9.66e-07	1.05e-05	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—CAT—rheumatoid arthritis	9.55e-07	1.04e-05	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TGFB1—rheumatoid arthritis	9.52e-07	1.04e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—ALB—rheumatoid arthritis	9.43e-07	1.03e-05	CbGpPWpGaD
Imatinib—ALB—Metabolism—PTGS2—rheumatoid arthritis	9.42e-07	1.02e-05	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—NOS3—rheumatoid arthritis	9.24e-07	1e-05	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—NOS3—rheumatoid arthritis	9.02e-07	9.81e-06	CbGpPWpGaD
Imatinib—PDGFRB—Signaling Pathways—IL6—rheumatoid arthritis	8.94e-07	9.72e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—ALB—rheumatoid arthritis	8.89e-07	9.66e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—ALB—rheumatoid arthritis	8.81e-07	9.58e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	8.5e-07	9.24e-06	CbGpPWpGaD
Imatinib—CYP2C19—Metabolism—PTGS2—rheumatoid arthritis	8.45e-07	9.19e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—NOS3—rheumatoid arthritis	8.43e-07	9.16e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—POMC—rheumatoid arthritis	8.26e-07	8.98e-06	CbGpPWpGaD
Imatinib—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	8.25e-07	8.97e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—MTHFR—rheumatoid arthritis	7.97e-07	8.66e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—TP53—rheumatoid arthritis	7.84e-07	8.52e-06	CbGpPWpGaD
Imatinib—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	7.77e-07	8.45e-06	CbGpPWpGaD
Imatinib—CYP2C9—Metabolism—PTGS2—rheumatoid arthritis	7.71e-07	8.38e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—ALB—rheumatoid arthritis	7.53e-07	8.19e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—NOS3—rheumatoid arthritis	7.2e-07	7.83e-06	CbGpPWpGaD
Imatinib—LCK—Signaling Pathways—IL6—rheumatoid arthritis	7.18e-07	7.8e-06	CbGpPWpGaD
Imatinib—CYP1A2—Metabolism—PTGS2—rheumatoid arthritis	6.59e-07	7.16e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—POMC—rheumatoid arthritis	6.37e-07	6.93e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—ALB—rheumatoid arthritis	5.81e-07	6.32e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—NOS3—rheumatoid arthritis	5.56e-07	6.04e-06	CbGpPWpGaD
Imatinib—CYP3A4—Metabolism—PTGS2—rheumatoid arthritis	5.08e-07	5.53e-06	CbGpPWpGaD
